Blood filter trial aims to pull COVID-19 virus from patients
NCT ID NCT04547257
First seen Apr 22, 2026 · Last updated Apr 22, 2026
Summary
This study is testing a device called the Seraph 100, which filters a patient's blood to remove the COVID-19 virus. It aims to help adults hospitalized with severe COVID-19 by reducing organ failure and improving survival. The main goal is to see if the filter is safe and if it helps patients recover better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clinico San Carlos
Madrid, 28040, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Klinikum Aschaffenburg-Alzenau
Aschaffenburg, 63739, Germany
-
Universitätsklinikum Essen
Essen, 45147, Germany
-
Vivantes Klinikum Neukölln
Berlin, 12351, Germany
Conditions
Explore the condition pages connected to this study.